亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease

四分位间距 医学 视神经脊髓炎 急性播散性脑脊髓炎 多发性硬化 视神经炎 扩大残疾状况量表 髓鞘少突胶质细胞糖蛋白 儿科 内科学 胃肠病学 免疫学 实验性自身免疫性脑脊髓炎
作者
Yael Hacohen,Yu Yi M. Wong,Christian Lechner,Maciej Juryńczyk,Sukhvir K. Wright,Bahadır Konuşkan,Judith Kalser,Anne‐Lise Poulat,Hélène Maurey,Esther Ganelin‐Cohen,Evangeline Wassmer,Chery Hemingway,Rob J Forsyth,Eva Maria Hennes,Maria Isabel Leite,Olga Ciccarelli,Banu Anlar,Rogier Q. Hintzen,Romain Marignier,Jacqueline A. Palace
出处
期刊:JAMA Neurology [American Medical Association]
卷期号:75 (4): 478-478 被引量:432
标识
DOI:10.1001/jamaneurol.2017.4601
摘要

Importance: Myelin oligodendrocyte glycoprotein antibodies (MOG-Abs) are consistently identified in a range of demyelinating disorders in adults and children. Current therapeutic strategies are largely center specific, and no treatments have been formally evaluated. Objective: To examine the clinical phenotypes, treatment responses, and outcomes of children with relapsing MOG-Ab-associated disease. Design, Setting, and Participants: This study prospectively collected demographic, clinical, and radiologic data from 102 patients from 8 countries of the EU Paediatric Demyelinating Disease Consortium from January 1, 2014, through December 31, 2016. Patients were treated according to local protocols. Main Outcomes and Measures: Annualized relapse rates (ARRs) and Expanded Disability Status Scale (EDSS) scores before and during treatment with disease-modifying drugs (DMDs). Results: A total of 102 children were identified (median [range] age, 7.0 [1.5-7.9] years; male to female ratio, 1.0:1.8; white to other race/ethnicity ratio, 3.6:1.0). Original diagnoses were neuromyelitis optica spectrum disorder (44 patients [43.1%]), acute disseminated encephalomyelitis followed by optic neuritis (20 [19.6%]), multiphasic disseminated encephalomyelitis (20 [19.6%]), and relapsing optic neuritis (18 [17.6%]). In all, 464 demyelinating events were reported. Treated patients had more relapses (median, 3.0; range, 1.0-17.0) than untreated patients (median, 1.0; range 1.0-7.0) (P = .009) and higher EDSS scores (median, 1.5; interquartile range, 0-2.5) than untreated patients (median, 1.0; interquartile range, 0-1.5) (P < .001). Fifty-two children (51.0%) received DMDs: 28 (53.8%) were treated with 1 DMD, 17 (32.7%) with 2, and 7 (13.5%) with 3 or more sequential DMDs. Patients relapsed during all treatments, with a total of 127 relapses on treatment reported. No changes in median ARR and EDSS score were observed between the preinitiation and postinitiation phases of interferon beta and glatiramer acetate treatment (n = 11). The median ARR was reduced from 1.84 to 1.0 with azathioprine (n = 20, P < .001), 1.79 to 0.52 with mycophenolate mofetil (n = 15, P = .003), and 2.12 to 0.67 with rituximab (n = 9, P < .001), although the median EDSS score remained unchanged. An improvement in ARR (from 2.16 to 0.51, P < .001) and EDSS score (from 2.2 to 1.2, P = .01) was observed in the 12 patients treated with regular intravenous immunoglobulins. Conclusions and Relevance: Although commonly used to treat patients with multiple sclerosis, DMDs were not associated with clinical improvement in children with MOG-Ab-associated disease, whereas azathioprine, mycophenolate mofetil, rituximab, and particularly intravenous immunoglobulins were associated with a reduction in relapse frequency. A correct diagnosis of relapsing MOG-Ab-associated disorders is therefore important to optimize immune treatment.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6.2的应助被纯情的阁采纳,获得100
5秒前
科研通AI6.2的应助被纯情的阁采纳,获得10
6秒前
科研通AI6.4的应助被纯情的阁采纳,获得10
6秒前
科研通AI6.2的应助被纯情的阁采纳,获得10
6秒前
12秒前
21秒前
善良的寒珊完成签到,获得积分10
21秒前
从容美女发布了新的文献求助10
27秒前
星辰大海的应助被纯情的阁采纳,获得10
27秒前
37秒前
大个的应助被交大·勒布朗采纳,获得30
51秒前
1分钟前
成就马里奥完成签到,获得积分10
1分钟前
1分钟前
1分钟前
纯情的阁发布了新的文献求助10
1分钟前
1分钟前
深情的从丹完成签到,获得积分10
1分钟前
1分钟前
阿丕啊呸完成签到,获得积分10
1分钟前
1分钟前
1分钟前
null的应助被伊比利亚的微风采纳,获得10
1分钟前
认真的笑卉完成签到,获得积分10
1分钟前
1分钟前
aba发布了新的文献求助10
1分钟前
hamburger完成签到,获得积分10
1分钟前
null的应助被等待若魔采纳,获得10
2分钟前
陶醉成协完成签到,获得积分10
2分钟前
haralee完成签到 ,获得积分10
2分钟前
2分钟前
乐正元正完成签到,获得积分10
2分钟前
时尚的蜜蜂完成签到,获得积分10
2分钟前
2分钟前
369ninja发布了新的文献求助10
2分钟前
2分钟前
2分钟前
Logan1001发布了新的文献求助10
2分钟前
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158789
求助须知:如何正确求助?哪些是违规求助? 9554476
关于积分的说明 21719316
捐赠科研通 7748389
什么是DOI,文献DOI怎么找? 3427080
关于科研通互助平台的介绍 2551987
邀请新用户注册赠送积分活动 2471354